Key Metrics
CiteScore 

9.8
Eigenfactor 

0.005 - 0.01
Impact Factor 

5 - 10
SJR 

Q1Neurology (clinical)

SNIP 

1.87
Recommended pre-submission checks
Powered by 

Topics Covered on CNS Drugs
CNS Drugs Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in CNS Drugs ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in CNS Drugs
Opioid Use Disorder Treatment Gaps and Emerging Therapeutics to Address Them.
- 19 May 2026
- CNS drugs
Enhancing Drug Response Prediction in Epilepsy with Emerging Multimodal Models: Focus on Clinical, Pharmacologic, and Genomic Factors.
- 16 May 2026
- CNS drugs
Clinical Predictors of Antidepressant Effects of Ketamine and Esketamine in Treatment-Resistant Unipolar and Bipolar Depression: A Systematic Review.
- 16 May 2026
- CNS drugs
Comment on "Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes".
- 14 May 2026
- CNS drugs
Authors' Reply to Damkier: Comment on "Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta Analysis of Congenital Malformations and Prenatal Outcomes".
- 14 May 2026
- CNS drugs
Correction: Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes.
- 14 May 2026
- CNS drugs
Opioid Use Disorder Treatment Gaps and Emerging Therapeutics to Address Them.
- 19 May 2026
- CNS drugs
Enhancing Drug Response Prediction in Epilepsy with Emerging Multimodal Models: Focus on Clinical, Pharmacologic, and Genomic Factors.
- 16 May 2026
- CNS drugs
Clinical Predictors of Antidepressant Effects of Ketamine and Esketamine in Treatment-Resistant Unipolar and Bipolar Depression: A Systematic Review.
- 16 May 2026
- CNS drugs
Comment on "Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes".
- 14 May 2026
- CNS drugs
Authors' Reply to Damkier: Comment on "Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta Analysis of Congenital Malformations and Prenatal Outcomes".
- 14 May 2026
- CNS drugs
Correction: Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes.
- 14 May 2026
- CNS drugs
FAQs on CNS Drugs
How long has CNS Drugs been actively publishing? 
What is the publishing frequency of CNS Drugs? 
How many articles did CNS Drugs publish last year? 
What is the eISSN & pISSN for CNS Drugs? 
What is Citescore for CNS Drugs? 
What is SNIP score for CNS Drugs? 
What is the SJR for CNS Drugs? 
Who is the publisher of CNS Drugs? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary